David Hess

David Hess is a career entrepreneur with a unique relationship to cannabis for the past two decades. A two time cancer survivor, David was introduced to the vast benefits of medical cannabis while undergoing cancer treatments in 2001 and again in 2003. David has since dedicated himself to furthering research, awareness, impact and business opportunities in the expanding cannabis industry. In 2013, David partnered with Asher Troppe, an experienced fiduciary and independent trader on Wall Street with over a decade's experience managing equity portfolios to establish Tress, the cannabis industry’s go to source for private capital, solutions and strategic support. Tress Capital is a strategic boutique private investment firm embedded at the core of the global cannabis sector originating and managing investments for HNW, family office, and institutional investors. Tress has a track record of successful industry investment and works closely with its companies and the industry providing active value-add support. The Tress portfolio includes impactful industry leaders such as SC Labs, Headset, TILT (by way of Baker Technologies), Cannabis Now, Grownetics, North Bud Farms, Infusion Biosciences, WasteTrakr and iCAN. With a unique industry network, unparalleled deal flow pipeline, successful portfolio investment track record and an experienced team with in house niche expertise, Tress Capital is the go to for sophisticated investors seeking competence while Tress Solutions provides M&A advisory, strategy, business development, and operational support to sector companies.